Craft

Advanced
  • Home
  •  / MyMD Pharmaceuticals
MyMD Pharmaceuticals

MyMD Pharmaceuticals

Stock Price

$1.3

2024-09-24

Market Capitalization

$4.3 M

2024-09-24

Revenue

$1.6 M

FY, 2019

MyMD Pharmaceuticals Summary

Company Summary

Overview
MyMD Pharmaceuticals (formerly known as Akers Biosciences) is a clinical-stage pharmaceutical company. It develops and commercializes two therapeutic platforms based on well-defined therapeutic targets, MYMD-1® and Supera-CBD.
Type
Public
Status
Active
Founded
2014
HQ
West Deptford, NJ, US | view all locations
Website
https://www.mymd.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Howard R. Yeaton, Interim Chief Financial Officer

    • Christopher C. Schreiber, President and Chief Executive Officer, Director

      • Joshua Silverman

        Joshua Silverman, Chairman

        • Bill J. White

          Bill J. White, Independent Director

          LocationsView all

          1 location detected

          • West Deptford, NJ HQ

            United States

            201 Grove Rd, Thorofare

          MyMD Pharmaceuticals Financials

          Summary Financials

          Net income (Q1, 2026)
          ($1.2M)
          Cash (Q1, 2026)
          $1.1M
          EBIT (Q1, 2026)
          ($1.9M)

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX